1 AEL( pS )PVEQKL

86
N Sequence AN rt IMAC rt Synt Ratio N Sequence AN rt IMAC rt Synt Ratio 1 AEL[pS]PVEQK L Q9Y5P8 60.1 55.6 1.1 44 REIES[pS]PQY RL Q8WWM7 48.9 46.1 1.1 2 REL[pS]PQRNL Q96F44 37.1 35.3 1.1 45 REY[pS]PPYAP Q9UPT8 51.3 48.0 1.1 3 TER[pS]PGPRL O14978 30.1 30.5 1.0 46 KEKEV[pS]QEL A8MX76 33.9 33.3 1.0 4 IES[pS]PQYRL Q8WWM7 52.9 49.8 1.1 47 KEL[pS]PPPGL Q7Z4S6 62.5 57.2 1.1 5 KEKDF[pS]PEA L O15372 51.1 47.6 1.1 48 RER[pS]PSPSF P49585 31.3 31.4 1.0 6 GEW[pS]ASLPH RF O43164 70.8 64.5 1.1 49 GET[pS]LMRTL O96017 70.7 64.5 1.1 7 SEA[pS]PSREA I Q13111 33.6 33.5 1.0 50 AEK[pS]PGPIV Q86WB0 39.5 38.0 1.0 8 YEG[pS]PIKVT L P06748 72.4 66.2 1.1 51 REN[pS]PVQSI Q7Z2Z1 35.7 35.0 1.0 9 HERSI[pS]PLL Q9UBT6 57.3 53.1 1.1 52 RET[pS]PNRIG L Q7Z460 42.6 40.4 1.1 10 VEKKKIR[pS]L O75394 18.2 19.9 0.9 53 REG[pS]FRVTT A P49757 38.4 36.9 1.0 11 AEN[pS]PTRQQ F Q86XP3 32.8 33.0 1.0 54 PEV[pS]PRPAL Q96L73 50.5 47.4 1.1 12 QEV[pT]PSRST L P49454 38.5 37.4 1.0 55 KEL[pS]PAGSI O95453 46.5 44.0 1.1 13 RE[pS]PPPSAL Q86VE0 37.5 36.5 1.0 56 REG[pS]YDRYL Q9HCD5 48.8 46.0 1.1 14 REK[pT]PSEDK L Q8NFC6 20.6 22.4 0.9 57 S[pS]YGNIRAV Q8N122 47.9 45.4 1.1 15 GEDR[pS]PPTA L Q9BUB5 40.9 39.6 1.0 58 GEPHS[pS]PEL Q9NUA8 35.8 33.8 1.1 16 REV[pS]PAPAV A O60292 34.9 34.2 1.0 59 REK[pS]PGRML ST O14578 27.6 28.2 1.0 17 KEV[pT]PKPVL P17544 43.0 40.8 1.1 60 SEL[pS]PGRSV Q8NFF5 39.8 38.4 1.0 18 HEL[pS]PPQKR M Q9BXP5 30.5 30.5 1.0 61 HEFS[pS]PSHL Q9H3D4 39.8 38.1 1.0 19 RE[pT]PSPRPM Q9UQ35 26.7 27.7 1.0 62 QEK[pS]PEERL Q7RTP6 26.4 27.5 1.0 20 REYG[pS]PLKA Q9UQ88 33.7 33.2 1.0 63 KEQ[pS]PEPHL Q5VV52 33.4 33.2 1.0 21 KEM[pS]PTRQL Q4G0N7 33.9 33.3 1.0 64 NEA[pS]PVKRP RL Q9H8U3 34.4 33.2 1.0 22 GENK[pS]PLLL Q8IZD2 62.6 57.7 1.1 65 G[pS]FSRFYSL P22695 82.0 72.7 1.1 23 VEFPH[pS]PEI Q9BR61 68.0 62.0 1.1 66 REF[pS]KEPEL Q9NQS7 49.8 46.6 1.1 24 YEKAN[pT]PEL Q9H8V3 40.3 39.1 1.0 67 SEKPV[pS]PKS GTL Q14155 34.3 33.5 1.0 25 VEK[pS]PRPPL Q7L590 37.2 35.4 1.1 68 REL[pS]PLISL P51825 89.3 80.0 1.1 26 QEK[pS]PKQAL O43683 22.2 24.0 0.9 69 RE[pT]PVPPAM Q9Y2F5 28.9 29.8 1.0 27 GEI[pS]PQREV Q8WWI1 41.8 40.1 1.0 70 REP[pS]PSSSS L O60336 34.8 34.1 1.0 28 HEFH[pS]QENL Q9Y3M8 32.6 32.4 1.0 71 LEKRT[pS]PQV L Q7Z417 37.3 35.4 1.1 Supplementary data S2. MS2 spectra of the identified phosphopeptides. Each candidate spectrum is compared with the fragmentation spectrum of the indicated synthetic peptide. Red dots represent ion peaks that are not present in both spectra. The retention times of each natural peptide in the IMAC fraction (rt IMAC) and of the corresponding synthetic peptide

description

- PowerPoint PPT Presentation

Transcript of 1 AEL( pS )PVEQKL

Page 1: 1 AEL( pS )PVEQKL

N Sequence AN rt IMAC rt Synt Ratio N Sequence AN rt IMAC rt Synt Ratio1 AEL[pS]PVEQKL Q9Y5P8 60.1 55.6 1.1 44 REIES[pS]PQYRL Q8WWM7 48.9 46.1 1.12 REL[pS]PQRNL Q96F44 37.1 35.3 1.1 45 REY[pS]PPYAP Q9UPT8 51.3 48.0 1.13 TER[pS]PGPRL O14978 30.1 30.5 1.0 46 KEKEV[pS]QEL A8MX76 33.9 33.3 1.04 IES[pS]PQYRL Q8WWM7 52.9 49.8 1.1 47 KEL[pS]PPPGL Q7Z4S6 62.5 57.2 1.15 KEKDF[pS]PEAL O15372 51.1 47.6 1.1 48 RER[pS]PSPSF P49585 31.3 31.4 1.06 GEW[pS]ASLPHR

F O43164 70.8 64.5 1.1 49 GET[pS]LMRTL O96017 70.7 64.5 1.17 SEA[pS]PSREAI Q13111 33.6 33.5 1.0 50 AEK[pS]PGPIV Q86WB0 39.5 38.0 1.08 YEG[pS]PIKVTL P06748 72.4 66.2 1.1 51 REN[pS]PVQSI Q7Z2Z1 35.7 35.0 1.09 HERSI[pS]PLL Q9UBT6 57.3 53.1 1.1 52 RET[pS]PNRIGL Q7Z460 42.6 40.4 1.1

10 VEKKKIR[pS]L O75394 18.2 19.9 0.9 53 REG[pS]FRVTTA P49757 38.4 36.9 1.011 AEN[pS]PTRQQF Q86XP3 32.8 33.0 1.0 54 PEV[pS]PRPAL Q96L73 50.5 47.4 1.112 QEV[pT]PSRSTL P49454 38.5 37.4 1.0 55 KEL[pS]PAGSI O95453 46.5 44.0 1.113 RE[pS]PPPSAL Q86VE0 37.5 36.5 1.0 56 REG[pS]YDRYL Q9HCD5 48.8 46.0 1.114 REK[pT]PSEDKL Q8NFC6 20.6 22.4 0.9 57 S[pS]YGNIRAV Q8N122 47.9 45.4 1.115 GEDR[pS]PPTAL Q9BUB5 40.9 39.6 1.0 58 GEPHS[pS]PEL Q9NUA8 35.8 33.8 1.116 REV[pS]PAPAVA O60292 34.9 34.2 1.0 59 REK[pS]PGRMLST O14578 27.6 28.2 1.017 KEV[pT]PKPVL P17544 43.0 40.8 1.1 60 SEL[pS]PGRSV Q8NFF5 39.8 38.4 1.018 HEL[pS]PPQKRM Q9BXP5 30.5 30.5 1.0 61 HEFS[pS]PSHL Q9H3D4 39.8 38.1 1.019 RE[pT]PSPRPM Q9UQ35 26.7 27.7 1.0 62 QEK[pS]PEERL Q7RTP6 26.4 27.5 1.020 REYG[pS]PLKA Q9UQ88 33.7 33.2 1.0 63 KEQ[pS]PEPHL Q5VV52 33.4 33.2 1.021 KEM[pS]PTRQL Q4G0N7 33.9 33.3 1.0 64 NEA[pS]PVKRPRL Q9H8U3 34.4 33.2 1.022 GENK[pS]PLLL Q8IZD2 62.6 57.7 1.1 65 G[pS]FSRFYSL P22695 82.0 72.7 1.123 VEFPH[pS]PEI Q9BR61 68.0 62.0 1.1 66 REF[pS]KEPEL Q9NQS7 49.8 46.6 1.124 YEKAN[pT]PEL Q9H8V3 40.3 39.1 1.0 67 SEKPV[pS]PKSGTL Q14155 34.3 33.5 1.025 VEK[pS]PRPPL Q7L590 37.2 35.4 1.1 68 REL[pS]PLISL P51825 89.3 80.0 1.126 QEK[pS]PKQAL O43683 22.2 24.0 0.9 69 RE[pT]PVPPAM Q9Y2F5 28.9 29.8 1.027 GEI[pS]PQREV Q8WWI1 41.8 40.1 1.0 70 REP[pS]PSSSSL O60336 34.8 34.1 1.028 HEFH[pS]QENL Q9Y3M8 32.6 32.4 1.0 71 LEKRT[pS]PQVL Q7Z417 37.3 35.4 1.129 REG[pS]GRFSL P57764 46.5 43.9 1.1 72 REL[pS]GTIKEI P30050 54.9 51.0 1.130 GEN[pS]GIGKL Q6P0N0 44.4 42.4 1.0 73 GEA[pS]PSHII Q9ULL5-3 51.2 47.9 1.131 SEI[pS]PIKGSV Q7Z5K2 53.4 50.0 1.1 74 GEQ[pS]PNVSL Q58WW2 50.0 47.7 1.032 SEK[pS]LENETL P23588 46.5 44.2 1.1 75 KE[pT]PDKVEL Q13610 40.6 38.7 1.033 RED[pS]QRPGAH

L Q32P51 24.0 25.3 0.9 76 NEFH[pS]PIGL Q06413 67.7 61.7 1.134 RED[pS]GTFSL O75569 59.6 55.4 1.1 77 REV[pS]PEPIV Q8N103 51.7 48.5 1.135 REA[pS]PSRLSV O75122 37.4 35.4 1.1 78 NEK[pS]PYASL Q6IQ21 45.0 43.1 1.036 SEQ[pS]LGQKL P33991 43.9 42.1 1.0 79 REL[pS]GTIKEIL P30050 78.0 68.9 1.137 REV[pS]PAPAV O60292 36.3 35.2 1.0 80 SERIMQL[pS]L Q81IY63 83.2 73.8 1.138 SERM[pS]LPLL Q15398 91.2 81.7 1.1 81 R[pS]FPTLPTL Q13761 88.4 79.1 1.139 SES[pS]PPKAM Q9UHB6 28.5 29.4 1.0 82 KES[pS]PIPSP Q01082 39.0 37.6 1.040 SEV[pS]PSGVGF Q6ULP2 65.3 60.1 1.1 83 SE[pS]GSNLHAL Q6P4F7 43.8 42.0 1.041 REK[pS]PGRML O14578 25.5 26.6 1.0 84 KELARQI[pS]F Q9Y385 54.2 50.3 1.142 SEF[pS]DVDKL O75665 70.3 63.8 1.1 85 KEN[pT]PPAL P31350 38.7 37.4 1.043 REA[pS]PLSSNKL Q9Y462 40.2 38.3 1.0

Supplementary data S2. MS2 spectra of the identified phosphopeptides. Each candidate spectrum is compared with the fragmentation spectrum of the indicated synthetic peptide. Red dots represent ion peaks that are not present in both spectra. The retention times of each natural peptide in the IMAC fraction (rt IMAC) and of the corresponding synthetic peptide (rt Sint) are shown. The ratio rt IMAC / rt Sint is also indicated.

Page 2: 1 AEL( pS )PVEQKL

1AEL(pS)PVEQKL

SyntheticPeptide

CandidateSpectrum

Page 3: 1 AEL( pS )PVEQKL

2REL(pS)PQRNL

SyntheticPeptide

CandidateSpectrum

Page 4: 1 AEL( pS )PVEQKL

3TER(pS)PGPRL

SyntheticPeptide

CandidateSpectrum

Page 5: 1 AEL( pS )PVEQKL

4IES(pS)PQYRL

SyntheticPeptide

CandidateSpectrum

Page 6: 1 AEL( pS )PVEQKL

5KEKDF(pS)PEAL

SyntheticPeptide

CandidateSpectrum

Page 7: 1 AEL( pS )PVEQKL

6GEW(pS)ASLPHRF

SyntheticPeptide

CandidateSpectrum

Page 8: 1 AEL( pS )PVEQKL

7SEA(pS)PSREAI

SyntheticPeptide

CandidateSpectrum

Page 9: 1 AEL( pS )PVEQKL

8YEG(pS)PIKVTL

SyntheticPeptide

CandidateSpectrum

Page 10: 1 AEL( pS )PVEQKL

9HERSI(pS)PLL

SyntheticPeptide

CandidateSpectrum

Page 11: 1 AEL( pS )PVEQKL

10VEKKKIR(pS)L

SyntheticPeptide

CandidateSpectrum

Page 12: 1 AEL( pS )PVEQKL

11AEN(pS)PTRQQF

SyntheticPeptide

CandidateSpectrum

Page 13: 1 AEL( pS )PVEQKL

12QEV(pT)PSRSTL

SyntheticPeptide

CandidateSpectrum

Page 14: 1 AEL( pS )PVEQKL

13RE(pS)PPPSAL

SyntheticPeptide

CandidateSpectrum

Page 15: 1 AEL( pS )PVEQKL

14REK(pT)PSEDKL

SyntheticPeptide

CandidateSpectrum

Page 16: 1 AEL( pS )PVEQKL

15GEDR(pS)PPTAL

SyntheticPeptide

CandidateSpectrum

Page 17: 1 AEL( pS )PVEQKL

16REV(pS)PAPAVA

SyntheticPeptide

CandidateSpectrum

Page 18: 1 AEL( pS )PVEQKL

17KEV(pT)PKPVL

SyntheticPeptide

CandidateSpectrum

Page 19: 1 AEL( pS )PVEQKL

18HEL(pS)PPQKRM

SyntheticPeptide

CandidateSpectrum

Page 20: 1 AEL( pS )PVEQKL

19RE(pT)PSPRPM

SyntheticPeptide

CandidateSpectrum

Page 21: 1 AEL( pS )PVEQKL

20REYG(pS)PLKA

SyntheticPeptide

CandidateSpectrum

Page 22: 1 AEL( pS )PVEQKL

21KEM(pS)PTRQL

SyntheticPeptide

CandidateSpectrum

Page 23: 1 AEL( pS )PVEQKL

22GENK(pS)PLLL

SyntheticPeptide

CandidateSpectrum

Page 24: 1 AEL( pS )PVEQKL

23VEFPH(pS)PEI

SyntheticPeptide

CandidateSpectrum

Page 25: 1 AEL( pS )PVEQKL

24YEKAN(pT)PEL

SyntheticPeptide

CandidateSpectrum

Page 26: 1 AEL( pS )PVEQKL

25VEK(pS)PRPPL

SyntheticPeptide

CandidateSpectrum

Page 27: 1 AEL( pS )PVEQKL

26QEK(pS)PKQAL

SyntheticPeptide

CandidateSpectrum

Page 28: 1 AEL( pS )PVEQKL

27GEI(pS)PQREV

SyntheticPeptide

CandidateSpectrum

Page 29: 1 AEL( pS )PVEQKL

28HEFH(pS)QENL

SyntheticPeptide

CandidateSpectrum

Page 30: 1 AEL( pS )PVEQKL

29REG(pS)GRFSL

SyntheticPeptide

CandidateSpectrum

Page 31: 1 AEL( pS )PVEQKL

30GEN(pS)GIGKL

SyntheticPeptide

CandidateSpectrum

Page 32: 1 AEL( pS )PVEQKL

31SEI(pS)PIKGSV

SyntheticPeptide

CandidateSpectrum

Page 33: 1 AEL( pS )PVEQKL

32SEK(pS)LENETL

SyntheticPeptide

CandidateSpectrum

Page 34: 1 AEL( pS )PVEQKL

33RED(pS)QRPGAHL

SyntheticPeptide

CandidateSpectrum

Page 35: 1 AEL( pS )PVEQKL

34RED(pS)GTFSL

SyntheticPeptide

CandidateSpectrum

Page 36: 1 AEL( pS )PVEQKL

35REA(pS)PSRLSV

SyntheticPeptide

CandidateSpectrum

Page 37: 1 AEL( pS )PVEQKL

36SEQ(pS)LGQKL

SyntheticPeptide

CandidateSpectrum

Page 38: 1 AEL( pS )PVEQKL

37REV(pS)PAPAV

SyntheticPeptide

CandidateSpectrum

Page 39: 1 AEL( pS )PVEQKL

38SERM(pS)LPLL

SyntheticPeptide

CandidateSpectrum

Page 40: 1 AEL( pS )PVEQKL

39SES(pS)PPKAM

SyntheticPeptide

CandidateSpectrum

Page 41: 1 AEL( pS )PVEQKL

40SEV(pS)PSGVGF

SyntheticPeptide

CandidateSpectrum

Page 42: 1 AEL( pS )PVEQKL

41REK(pS)PGRML

SyntheticPeptide

CandidateSpectrum

Page 43: 1 AEL( pS )PVEQKL

42SEF(pS)DVDKL

SyntheticPeptide

CandidateSpectrum

Page 44: 1 AEL( pS )PVEQKL

43REA(pS)PLSSNKL

SyntheticPeptide

CandidateSpectrum

Page 45: 1 AEL( pS )PVEQKL

44REIES(pS)PQYRL

SyntheticPeptide

CandidateSpectrum

Page 46: 1 AEL( pS )PVEQKL

45REY(pS)PPYAP

SyntheticPeptide

CandidateSpectrum

Page 47: 1 AEL( pS )PVEQKL

46KEKEV(pS)QEL

SyntheticPeptide

CandidateSpectrum

Page 48: 1 AEL( pS )PVEQKL

47KEL(pS)PPPGL

SyntheticPeptide

CandidateSpectrum

Page 49: 1 AEL( pS )PVEQKL

48RER(pS)PSPSF

SyntheticPeptide

CandidateSpectrum

Page 50: 1 AEL( pS )PVEQKL

49GET(pS)LMRTL

SyntheticPeptide

CandidateSpectrum

Page 51: 1 AEL( pS )PVEQKL

50AEK(pS)PGPIV

SyntheticPeptide

CandidateSpectrum

Page 52: 1 AEL( pS )PVEQKL

51REN(pS)PVQSI

SyntheticPeptide

CandidateSpectrum

Page 53: 1 AEL( pS )PVEQKL

52RET(pS)PNRIGL

SyntheticPeptide

CandidateSpectrum

Page 54: 1 AEL( pS )PVEQKL

53REG(pS)FRVTTA

SyntheticPeptide

CandidateSpectrum

Page 55: 1 AEL( pS )PVEQKL

54PEV(pS)PRPAL

SyntheticPeptide

CandidateSpectrum

Page 56: 1 AEL( pS )PVEQKL

55KEL(pS)PAGSI

SyntheticPeptide

CandidateSpectrum

Page 57: 1 AEL( pS )PVEQKL

56REG(pS)YDRYL

SyntheticPeptide

CandidateSpectrum

Page 58: 1 AEL( pS )PVEQKL

57S(pS)YGNIRAV

SyntheticPeptide

CandidateSpectrum

Page 59: 1 AEL( pS )PVEQKL

58GEPHS(pS)PEL

SyntheticPeptide

CandidateSpectrum

Page 60: 1 AEL( pS )PVEQKL

59REK(pS)PGRMLST

SyntheticPeptide

CandidateSpectrum

Page 61: 1 AEL( pS )PVEQKL

60SEL(pS)PGRSV

SyntheticPeptide

CandidateSpectrum

Page 62: 1 AEL( pS )PVEQKL

61HEFS(pS)PSHL

SyntheticPeptide

CandidateSpectrum

Page 63: 1 AEL( pS )PVEQKL

62QEK(pS)PEERL

SyntheticPeptide

CandidateSpectrum

Page 64: 1 AEL( pS )PVEQKL

63KEQ(pS)PEPHL

SyntheticPeptide

CandidateSpectrum

Page 65: 1 AEL( pS )PVEQKL

64NEA(pS)PVKRPRL

SyntheticPeptide

CandidateSpectrum

Page 66: 1 AEL( pS )PVEQKL

65G(pS)FSRFYSL

SyntheticPeptide

CandidateSpectrum

Page 67: 1 AEL( pS )PVEQKL

66REF(pS)KEPEL

SyntheticPeptide

CandidateSpectrum

Page 68: 1 AEL( pS )PVEQKL

67SEKPV(pS)PKSGTL

SyntheticPeptide

CandidateSpectrum

Page 69: 1 AEL( pS )PVEQKL

68REL(pS)PLISL

SyntheticPeptide

CandidateSpectrum

Page 70: 1 AEL( pS )PVEQKL

69RE(pT)PVPPAM

SyntheticPeptide

CandidateSpectrum

Page 71: 1 AEL( pS )PVEQKL

70REP(pS)PSSSSL

SyntheticPeptide

CandidateSpectrum

Page 72: 1 AEL( pS )PVEQKL

71LEKRT(pS)PQVL

SyntheticPeptide

CandidateSpectrum

Page 73: 1 AEL( pS )PVEQKL

72REL(pS)GTIKEI

SyntheticPeptide

CandidateSpectrum

Page 74: 1 AEL( pS )PVEQKL

73GEA(pS)PSHII

SyntheticPeptide

CandidateSpectrum

Page 75: 1 AEL( pS )PVEQKL

74GEQ(pS)PNVSL

SyntheticPeptide

CandidateSpectrum

Page 76: 1 AEL( pS )PVEQKL

75KE(pT)PDKVEL

SyntheticPeptide

CandidateSpectrum

Page 77: 1 AEL( pS )PVEQKL

76NEFH(pS)PIGL

SyntheticPeptide

CandidateSpectrum

Page 78: 1 AEL( pS )PVEQKL

77REV(pS)PEPIV

SyntheticPeptide

CandidateSpectrum

Page 79: 1 AEL( pS )PVEQKL

78NEK(pS)PYASL

SyntheticPeptide

CandidateSpectrum

Page 80: 1 AEL( pS )PVEQKL

79REL(pS)GTIKEIL

SyntheticPeptide

CandidateSpectrum

Page 81: 1 AEL( pS )PVEQKL

80SERIMQL(pS)L

SyntheticPeptide

CandidateSpectrum

Page 82: 1 AEL( pS )PVEQKL

81R(pS)FPTLPTL

SyntheticPeptide

CandidateSpectrum

Page 83: 1 AEL( pS )PVEQKL

82KES(pS)PIPSP

SyntheticPeptide

CandidateSpectrum

Page 84: 1 AEL( pS )PVEQKL

83SE(pS)GSNLHAL

SyntheticPeptide

CandidateSpectrum

Page 85: 1 AEL( pS )PVEQKL

84KELARQI(pS)F

SyntheticPeptide

CandidateSpectrum

Page 86: 1 AEL( pS )PVEQKL

85KEN(pT)PPAL

SyntheticPeptide

CandidateSpectrum